project id: TCGA-GBM; case submitter id: TCGA-06-A7TL; analyte type: DNA; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.29; rna integrity number: 8.6; age at index: 30; days to birth: -11297; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1983; age at diagnosis: 11297; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 539.0; icd 10 code: C71.8; last known disease status: not reported; morphology: 9440/3; primary diagnosis: Glioblastoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Overlapping lesion of brain; synchronous malignancy: No; tissue or organ of origin: Overlapping lesion of brain; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 27; initial weight: 520.0; oct embedded: false; preservation method: Unknown; sample id: 5398667c-8d52-4ba0-80e0-e8376dc8c87d; sample submitter id: TCGA-06-A7TL-01A; portion id: 02a020d6-26ec-4bb6-9a96-587eb411de8e; portion submitter id: TCGA-06-A7TL-01A-11; slide id: 81388be6-4726-48ce-8d9d-5f1aced2b3c9; slide submitter id: TCGA-06-A7TL-01A-01-TS1; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 20.0; percent stromal cells: 30.0; percent tumor cells: 50.0; percent tumor nuclei: 80.0; section location: TOP;